Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer : based on the GlaxoSmithKline-sponsored satellite symposium, held et ECCO 14 : 24th September 2007, Barcelona, Spain (Elsevier, 2008)
EJC supplements, ISSN 1359-6349 vol. 6, no.5, March 2008
Keywords: Antibodies, Monoclonal; nádory prsu; monoklonální protilátky; Genes, erbB-2; geny erbB-2; ErbB Receptors; erbB receptory; gynekologie a porodnictví; Breast Neoplasms; farmakoterapie; onkologie